Article
Doxorubicin-conjugated dexamethasone induced MCF-7 apoptosis without entering the nucleus…
Drug Design, Development and Therapy · 2018 · Chaikomon K, Chattong S, Chaiya T, Tiwawech D, Sritana-Anant Y, Sereemaspun A, Manotham K
Key facts
| Title | Doxorubicin-conjugated dexamethasone induced MCF-7 apoptosis without entering the nucleus and able to overcome MDR-1-induced resistance |
|---|---|
| First author | Chaikomon K, Chattong S, Chaiya T, Tiwawech D, Sritana-Anant Y, Sereemaspun A, Manotham K |
| Journal | Drug Design, Development and Therapy |
| Published | Aug 1, 2018 |
| DOI | 10.2147/DDDT.S168588 |
| Devices mentioned | K111034, K120836, K800552, K853723, K860811, K862004, K874160, K874609, K912581, K915561, K915840, K920529 and 12 more |
| Product codes mentioned | EPT, GCJ, GCT, GEX, HET, HJO, HLI, HLQ, HQF, KKX, NGT, MVU |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1